• Home
  • About IBT
    • Vision and Mission
    • IBT History
    • Management
    • Board of Directors
    • Advisory Board
    • Sustainability Policy
  • Families
  • Healthcare Professionals
  • Science
    • Pipeline
    • IBP-9414
    • IBP-1016
    • Publications
  • Investors & Media
    • Shares
    • Presentations
    • Share Issue
    • Ownership Structure
    • Corporate Governance
    • Calendar
    • Financial Reports
    • Press Releases
    • News
    • Investors & Media Contact
    • Subscribe
  • Contact Us
  • Career
IBT Logo IBT Logo
  • En
  • Sv
  • Home
  • About IBT
    • Vision and Mission
    • IBT History
    • Management
    • Board of Directors
    • Advisory Board
    • Sustainability Policy
  • Families
  • Healthcare Professionals
  • Science
    • Pipeline
    • IBP-9414
    • IBP-1016
    • Publications
  • Investors & Media
    • Shares
    • Presentations
    • Share Issue
    • Ownership Structure
    • Corporate Governance
    • Calendar
    • Financial Reports
    • Press Releases
    • News
    • Investors & Media Contact
    • Subscribe
  • Contact Us
  • Career

Press releases


Prospectus relating to IBT’s rights issue published

To access the press release, please read the following disclaimer here.

April 27, 2016

Latest press releases

Infant Bacterial Therapeutics AB appoints Maria Ekdahl as CFO
Annual General Meeting of Infant Bacterial Therapeutics
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – March 31, 2022
Notice to attend the Annual General Meeting of Infant Bacterial Therapeutics
Infant Bacterial Therapeutics publishes Annual Report for 2021
This site uses cookies – small text-based files that are placed on your device to help us provide a better user experience. Find out more.
Contact | info@ibtherapeutics.com
© Copyright Infant Bacterial Therapeutics AB 2022
Cookie Policy Privacy Policy Terms of Use